Royal Bank of Canada’s Lyra Therapeutics LYRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10K | Buy |
1,102
+942
| +589% | +$8.55K | ﹤0.01% | 6101 |
|
|
2025
Q1 | $1K | Buy |
160
+54
| +51% | +$338 | ﹤0.01% | 6294 |
|
|
2024
Q4 | $2K | Sell |
106
-17
| -14% | -$321 | ﹤0.01% | 6217 |
|
|
2024
Q3 | $1K | Buy |
123
+26
| +27% | +$211 | ﹤0.01% | 6250 |
|
|
2024
Q2 | $1K | Buy |
97
+84
| +646% | +$866 | ﹤0.01% | 6454 |
|
|
2024
Q1 | $4K | Sell |
13
-53
| -80% | -$16.3K | ﹤0.01% | 6062 |
|
|
2023
Q4 | $17K | Buy |
66
+1
| +2% | +$258 | ﹤0.01% | 5820 |
|
|
2023
Q3 | $13K | Buy |
65
+64
| +6,400% | +$12.8K | ﹤0.01% | 5840 |
|
|
2023
Q2 | $0 | Buy |
+1
| New | – | ﹤0.01% | 6958 |
|
|
2023
Q1 | – | Sell |
-10
| Closed | -$2K | – | 6813 |
|
|
2022
Q4 | $2K | Buy |
10
+7
| +233% | +$1.4K | ﹤0.01% | 6462 |
|
|
2022
Q3 | $1K | Buy |
+3
| New | +$1K | ﹤0.01% | 6724 |
|
|
2022
Q2 | – | Sell |
-2
| Closed | – | – | 7022 |
|
|
2022
Q1 | $0 | Hold |
2
| – | – | ﹤0.01% | 7328 |
|
|
2021
Q4 | $0 | Sell |
2
-4
| -67% | – | ﹤0.01% | 7195 |
|
|
2021
Q3 | $3K | Sell |
6
-2
| -25% | -$1K | ﹤0.01% | 6739 |
|
|
2021
Q2 | $3K | Sell |
8
-36
| -82% | -$13.5K | ﹤0.01% | 6676 |
|
|
2021
Q1 | $25K | Sell |
44
-3
| -6% | -$1.71K | ﹤0.01% | 5802 |
|
|
2020
Q4 | $27K | Buy |
+47
| New | +$27K | ﹤0.01% | 5376 |
|